Sethuraman Raghuraman M, Parida Satyen, Sethuramachandran Adinarayanan, Selvam Priyanka
Department of Anaesthesiology, Sree Balaji Medical College and Hospital (BIHER), Chennai, India.
Department of Anaesthesiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Turk J Anaesthesiol Reanim. 2022 Apr;50(2):79-85. doi: 10.5152/TJAR.2021.854.
Hemoglobin A1c (A1C) or glycated hemoglobin reflects the levels of blood glucose during the previous 8-12 weeks duration. It also helps us to diagnose diabetes in some cases, during the preoperative screening, who were initially missed out. Although the number of patients with diabetes undergoing various surgeries has increased many times, the role of A1C as a predictor for the complications during the perioperative phase remains intriguing. This could be due to various factors such as lack of best shreds of evidence, various cut-off levels of target A1C, variations of the patient population, presence of other comorbid conditions, and so on. This narrative review article presents the role of A1C as a reflector of perioperative adverse events in various surgeries and discusses the controversies surrounding it. We searched "PubMed Central" database with search criteria of "hemoglobin A1c, glycated hemoglobin, and perioperative complications" with publication date from January 01, 2010, to January 31, 2020, and found a total of 214 articles. We included only the relevant articles to our topic and added a few more articles that we found as "secondary references" from those articles to suit the structured headings of our narrative review and made it a total of fifty. To our knowledge, the majority of the studies published on this topic are of the "Retrospective analysis" type of study, besides no narrative review article available to date in the literature. We suggest that assessment of A1C levels preoperatively can be used as a routine practice for major procedures in patients with diabetes and for patients who have persistent high glucose values during preoperative screening regardless of whether a diagnosis of diabetes is established or not. We found that a cut-off of 8% is acceptable for the majority of the surgical procedures. However, it is better to have a cut-off of 7% or lower for procedures such as spine and joint replacement surgeries, cardiac surgeries, and so on. Further prospective studies involving a large population preferably with a multicenter design would provide us more clarity on this topic.
糖化血红蛋白A1c(A1C)或糖化血红蛋白反映了过去8至12周期间的血糖水平。在某些情况下,它还能帮助我们在术前筛查中诊断出最初被漏诊的糖尿病患者。尽管接受各种手术的糖尿病患者数量增加了许多倍,但A1C作为围手术期并发症预测指标的作用仍不明确。这可能是由于多种因素,如缺乏最佳证据、目标A1C的不同临界值、患者群体的差异、其他合并症的存在等。这篇叙述性综述文章介绍了A1C作为各种手术围手术期不良事件反映指标的作用,并讨论了围绕它的争议。我们在“PubMed Central”数据库中以“糖化血红蛋白A1c、糖化血红蛋白和围手术期并发症”为检索标准,检索了2010年1月1日至2020年1月31日发表的文献,共找到214篇文章。我们只纳入了与我们主题相关的文章,并从这些文章中添加了一些我们作为“二次参考文献”找到的文章,以符合我们叙述性综述的结构化标题要求,最终共五十篇。据我们所知,关于这个主题发表的大多数研究都是“回顾性分析”类型的研究,而且迄今为止文献中没有叙述性综述文章。我们建议,术前评估A1C水平可作为糖尿病患者进行大手术以及术前筛查中血糖持续偏高患者(无论是否确诊糖尿病)的常规做法。我们发现,大多数外科手术的临界值为8%是可以接受的。然而,对于脊柱和关节置换手术、心脏手术等,临界值最好为7%或更低。进一步开展涉及大量人群、最好采用多中心设计的前瞻性研究,将使我们对这个主题有更清晰的认识。